Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A

The first phase IIb safety and efficacy trial of a new tuberculosis vaccine since that for BCG was completed in October 2012. BCG-vaccinated South African infants were randomized to receive modified vaccinia virus Ankara, expressing the Mycobacterium tuberculosis antigen 85A (MVA85A), or placebo. MV...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Stephanie A., Satti, Iman, Matsumiya, Magali, Stockdale, Lisa, Chomka, Agnieszka, Tanner, Rachel, O'Shea, Matthew K., Manjaly Thomas, Zita-Rose, Tameris, Michele, Mahomed, Hassan, Scriba, Thomas J., Hanekom, Willem A., Fletcher, Helen A., McShane, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2014
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097435/
https://www.ncbi.nlm.nih.gov/pubmed/24828094
http://dx.doi.org/10.1128/CVI.00128-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097435/
https://www.ncbi.nlm.nih.gov/pubmed/24828094
http://dx.doi.org/10.1128/CVI.00128-14

Ejemplares similares